LAZARD ASSET MANAGEMENT LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 151 filers reported holding REVANCE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$885
-68.1%
77,200
-10.4%
0.00%
-75.0%
Q1 2023$2,775
-98.2%
86,155
+676.2%
0.00%
Q2 2022$153,000
-52.6%
11,099
-33.1%
0.00%
Q1 2022$323,000
-20.8%
16,583
-33.8%
0.00%
Q4 2021$408,000
+2300.0%
25,048
+4131.1%
0.00%
Q2 2021$17,000
-94.7%
592
-94.8%
0.00%
Q1 2021$320,000
-29.8%
11,456
-28.9%
0.00%
-100.0%
Q4 2020$456,00016,1180.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$52,671,00026.22%
NovaQuest Capital Management, L.L.C. 1,558,426$24,561,00022.85%
Sio Capital Management, LLC 254,581$4,012,0001.08%
ArrowMark Colorado Holdings LLC 3,409,217$53,729,0000.51%
Fosun International Ltd 472,532$7,447,0000.47%
Rhenman & Partners Asset Management AB 193,181$3,045,0000.36%
Phoenix Investment Adviser LLC 4,900$77,0000.17%
HARBOURVEST PARTNERS LLC 26,565$419,0000.15%
Quinn Opportunity Partners LLC 56,672$893,0000.12%
MFN Partners Management, LP 46,000$725,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders